Received Jul 30, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Suspected vaccination failure; I have had all of the shots/ three years ago I got the two shots set, since then I've had shingles twice in my eye; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) solution for injection for prophylaxis. The patient's past medical history included ophthalmic herpes zoster (gotten shingles in eyes) and facial herpes zoster (gotten shingles down face, up nose, across eye). Previously administered products included Shingles vaccine with an associated reaction of ophthalmic herpes zoster (patient got the one as soon as he/she was able to on an unknown date). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and ophthalmic herpes zoster (Verbatim: I have had all of the shots/ three years ago I got the two shots set, since then I've had shingles twice in my eye) (serious criteria GSK medically significant). The outcome of the vaccination failure and ophthalmic herpes zoster were not reported. It was unknown if the reporter considered the vaccination failure and ophthalmic herpes zoster to be related to Shingles vaccine. The company considered the vaccination failure and ophthalmic herpes zoster to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 26-JUL-2026 This case was reported by a patient via interactive digital media. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation regarding ophthalmic herpes zoster were unknown at the time of reporting. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Vaccination failure and Ophthalmic herpes zoster, on an unknown time after vaccination with the 1st and 2nd dose of Shingles vaccine, in a patient. Based on the available information a possible causality that the events were caused by GSK vaccine product cannot be ascertained. Consent for further follow up has not been received.
Medical History/Concurrent Conditions: Facial herpes zoster (gotten shingles down face, up nose, across eye); Ophthalmic herpes zoster (gotten shingles in eyes)